Journals / art / 2014 / Cilt: 29 - Sayı: 2

Expression of survivin in patients with refractory rheumatoid arthritis in a chinese population

Journal
art
Pages
81–87
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results of this study showed that survivin is overexpressed in refractory RA patients and the serum survivin level is correlated with disease activity.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: This study aims to investigate whether the expression of survivin is associated with refractory rheumatoid arthritis (RA) among Chinese patients.
📊
Key Findings & Data:Patients and methods: We evaluated the expression of survivin in serum and synovial tissues in 60 patients of RA and 20 healthy controls.
💡
Conclusion & Impact:Conclusion: The results of this study showed that survivin is overexpressed in refractory RA patients and the serum survivin level is correlated with disease activity.
🔬Design:Research Article
📍Scope:51 samples
⚙️Variables:Domain Parameters

Abstract

Objectives: This study aims to investigate whether the expression of survivin is associated with refractory rheumatoid arthritis (RA) among Chinese patients. Patients and methods: We evaluated the expression of survivin in serum and synovial tissues in 60 patients of RA and 20 healthy controls. Rheumatoid arthritis patients were divided into three groups: 20 patients in the untreated group, 20 patients in the treatment-responsive group and 20 patients in the treatment refractory group. Serum concentrations of survivin in four groups were measured by enzyme-linked immunosorbent assay. Clinical features and laboratory test results including disease duration, complete blood count, erythrocyte sedimentation rate, C-reactive protein, rheumatoid factor and anti-cyclic citrullinated peptide antibody were recorded. Expression levels of survivin in synovial tissue of all 51 samples were tested by immunohistochemical technique. Results: The survivin level was significantly higher in the refractory group than healthy controls (270.04±23.03 pg/ml vs. 116.68±19.07 pg/ml, p<0.05) and treatment-responsive group (270.04±23.03 pg/ml vs. 127.37±11.42 pg/ml, p<0.05). The survivin level in refractory RA patients was positively correlated with the Disease Activity Score 28. Immunohistochemical analysis revealed that survivin expression was significantly higher in the synovial tissues of refractory RA patients compared to treatment-responsive patients and healthy controls. Conclusion: The results of this study showed that survivin is overexpressed in refractory RA patients and the serum survivin level is correlated with disease activity.

🔖

Cite This Article

LONG, X. M., CHEN, J., WANG, W. J., WANG, J. (2014). Expression of survivin in patients with refractory rheumatoid arthritis in a chinese population. art, Cilt: 29 - Sayı: 2, 81–87. https://ajindex.com/articles/200491

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. van de Putte LB, Kroot EJ, van Riel PL. Management of refractory rheumatoid arthritis. Rheumatology (Oxford) 1999;38 Suppl 2:32–4
  2. Tsujimura S, Saito K, Nawata M, Nakayamada S, Tanaka Y. Overcoming drug resistance induced by P-glycoprotein on lymphocytes in patients with refractory rheumatoid arthritis. Ann Rheum Dis 2008;67:380–8
  3. Morgan C, Lunt M, Brightwell H, Bradburn P, Fallow W, Lay M, et al. Contribution of patient related differences to multidrug resistance in rheumatoid arthritis. Ann Rheum Dis 2003;62:15–9
  4. Bokarewa M, Lindblad S, Bokarew D, Tarkowski A. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Arthritis Res Ther 2005;7:R349–58
  5. Chen J, Chen L, Mao N, Liu Y. Association of the MDR1 3435 polymorphism in patients with refractory rheumatoid arthritis in a Chinese population. Rheumatol Int 2012;32:3127–30
  6. Isgren A, Forslind K, Erlandsson M, Axelsson C, Andersson S, Lund A, et al. High survivin levels predict poor clinical response to infliximab treatment in patients with rheumatoid arthritis. Semin Arthritis Rheum 2012;41:652–7
  7. Deveraux QL, Reed JC. IAP family proteins-- suppressors of apoptosis. Genes Dev 1999;13:239–52
  8. Mita AC, Mita MM, Nawrocki ST, Giles FJ. Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 2008;14:5000–5
  9. Svensson B, Hafström I, Forslind K, Albertsson K, Tarkowski A, Bokarewa M. Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis. Ann Med 2010;42:45–54
  10. Bokarewa M, Tarkowski A, Magnusson M. Pathological survivin expression links viral infections with pathogenesis of erosive rheumatoid arthritis. Scand J Immunol 2007;66:192–8
  11. Ahn JK, Oh JM, Lee J, Bae EK, Ahn KS, Cha HS, et al. Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin. Inflammation 2010;33:381–8
  12. Lequerré T, Richez C. Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis. Rev Prat 2012;62:1088–9
  13. Che XF, Zheng CL, Owatari S, Mutoh M, Gotanda T, Jeung HC, et al. Overexpression of survivin in primary ATL cells and sodium arsenite induces apoptosis by down-regulating survivin expression in AT